BLCM Annual SG&A
$5.72 M
-$1.29 M-18.45%
31 December 2022
Summary:
As of February 5, 2025, BLCM annual selling, general & administrative expenses is $5.72 million, with the most recent change of -$1.29 million (-18.45%) on December 31, 2022. During the last 3 years, it has fallen by -$24.25 million (-80.93%).BLCM Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BLCM Quarterly SG&A
$1.51 M
-$748.00 K-33.11%
01 September 2023
Summary:
As of February 5, 2025, BLCM quarterly selling, general & administrative expenses is $1.51 million, with the most recent change of -$748.00 thousand (-33.11%) on September 1, 2023. Over the past year, it has increased by +$196.00 thousand (+14.90%).BLCM Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BLCM TTM SG&A
-$2.34 B
-$22.38 M-0.96%
01 September 2023
Summary:
As of February 5, 2025, BLCM TTM selling, general & administrative expenses is -$2.34 billion, with the most recent change of -$22.38 million (-0.96%) on September 1, 2023. Over the past year, it has dropped by -$2.35 billion (-40692.32%).BLCM TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BLCM Selling, General & Administrative Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -18.4% | +14.9% | -10000.0% |
| 3 y3 years | -80.9% | -63.7% | -10000.0% |
| 5 y5 years | -73.9% | -78.7% | -7911.8% |
BLCM Selling, General & Administrative Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time | -80.9% | -83.6% | -7673.6% |
Bellicum Pharmaceuticals Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2023 | - | $1.51 M(-33.1%) | $6.71 M(+3.0%) |
| June 2023 | - | $2.26 M(+57.2%) | $6.51 M(+14.2%) |
| Mar 2023 | - | $1.44 M(-4.3%) | $5.70 M(-0.3%) |
| Dec 2022 | $5.72 M(-18.4%) | $1.50 M(+14.1%) | $5.72 M(-0.9%) |
| Sept 2022 | - | $1.31 M(-9.2%) | $5.77 M(-6.0%) |
| June 2022 | - | $1.45 M(-0.3%) | $6.13 M(-4.9%) |
| Mar 2022 | - | $1.45 M(-6.4%) | $6.45 M(-8.0%) |
| Dec 2021 | $7.01 M(-54.9%) | $1.55 M(-7.7%) | $7.01 M(-21.2%) |
| Sept 2021 | - | $1.68 M(-4.8%) | $8.89 M(-21.8%) |
| June 2021 | - | $1.76 M(-12.3%) | $11.38 M(-14.9%) |
| Mar 2021 | - | $2.01 M(-41.4%) | $13.37 M(-13.9%) |
| Dec 2020 | $15.53 M(-48.2%) | $3.44 M(-17.5%) | $15.53 M(-12.8%) |
| Sept 2020 | - | $4.16 M(+10.7%) | $17.80 M(-22.1%) |
| June 2020 | - | $3.76 M(-9.8%) | $22.85 M(-14.1%) |
| Mar 2020 | - | $4.17 M(-26.9%) | $26.61 M(-11.2%) |
| Dec 2019 | $29.97 M(+19.9%) | $5.71 M(-38.0%) | $29.97 M(-3.1%) |
| Sept 2019 | - | $9.21 M(+22.5%) | $30.91 M(+7.3%) |
| June 2019 | - | $7.52 M(-0.2%) | $28.81 M(+7.5%) |
| Mar 2019 | - | $7.54 M(+13.3%) | $26.81 M(+7.3%) |
| Dec 2018 | $25.00 M | $6.65 M(-6.4%) | $25.00 M(+6.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2018 | - | $7.11 M(+28.8%) | $23.41 M(+11.3%) |
| June 2018 | - | $5.52 M(-3.6%) | $21.04 M(-1.5%) |
| Mar 2018 | - | $5.72 M(+12.9%) | $21.35 M(-2.6%) |
| Dec 2017 | $21.91 M(+25.2%) | $5.07 M(+7.1%) | $21.91 M(+2.6%) |
| Sept 2017 | - | $4.73 M(-18.9%) | $21.35 M(+2.3%) |
| June 2017 | - | $5.83 M(-7.2%) | $20.87 M(+7.7%) |
| Mar 2017 | - | $6.28 M(+39.3%) | $19.37 M(+10.7%) |
| Dec 2016 | $17.50 M(+10.4%) | $4.51 M(+6.1%) | $17.50 M(-12.5%) |
| Sept 2016 | - | $4.25 M(-1.8%) | $20.00 M(+1.9%) |
| June 2016 | - | $4.33 M(-1.9%) | $19.63 M(+8.6%) |
| Mar 2016 | - | $4.41 M(-36.9%) | $18.07 M(+14.0%) |
| Dec 2015 | $15.86 M(+265.8%) | $7.00 M(+80.3%) | $15.86 M(+46.0%) |
| Sept 2015 | - | $3.88 M(+39.8%) | $10.86 M(+31.2%) |
| June 2015 | - | $2.78 M(+26.4%) | $8.28 M(+35.9%) |
| Mar 2015 | - | $2.20 M(+9.7%) | $6.09 M(+40.5%) |
| Dec 2014 | $4.33 M(+120.7%) | $2.00 M(+54.1%) | $4.33 M(+88.6%) |
| Sept 2014 | - | $1.30 M(+119.6%) | $2.30 M(+130.2%) |
| June 2014 | - | $592.00 K(+34.5%) | $998.70 K(+145.6%) |
| Mar 2014 | - | $440.00 K(-1421.3%) | $406.70 K(-1321.3%) |
| Dec 2013 | $1.96 M(+1.1%) | -$33.30 K | -$33.30 K |
| Dec 2012 | $1.94 M | - | - |
FAQ
- What is Bellicum Pharmaceuticals annual selling, general & administrative expenses?
- What is the all time high annual SG&A for Bellicum Pharmaceuticals?
- What is Bellicum Pharmaceuticals annual SG&A year-on-year change?
- What is Bellicum Pharmaceuticals quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for Bellicum Pharmaceuticals?
- What is Bellicum Pharmaceuticals quarterly SG&A year-on-year change?
- What is Bellicum Pharmaceuticals TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for Bellicum Pharmaceuticals?
- What is Bellicum Pharmaceuticals TTM SG&A year-on-year change?
What is Bellicum Pharmaceuticals annual selling, general & administrative expenses?
The current annual SG&A of BLCM is $5.72 M
What is the all time high annual SG&A for Bellicum Pharmaceuticals?
Bellicum Pharmaceuticals all-time high annual selling, general & administrative expenses is $29.97 M
What is Bellicum Pharmaceuticals annual SG&A year-on-year change?
Over the past year, BLCM annual selling, general & administrative expenses has changed by -$1.29 M (-18.45%)
What is Bellicum Pharmaceuticals quarterly selling, general & administrative expenses?
The current quarterly SG&A of BLCM is $1.51 M
What is the all time high quarterly SG&A for Bellicum Pharmaceuticals?
Bellicum Pharmaceuticals all-time high quarterly selling, general & administrative expenses is $9.21 M
What is Bellicum Pharmaceuticals quarterly SG&A year-on-year change?
Over the past year, BLCM quarterly selling, general & administrative expenses has changed by +$196.00 K (+14.90%)
What is Bellicum Pharmaceuticals TTM selling, general & administrative expenses?
The current TTM SG&A of BLCM is -$2.34 B
What is the all time high TTM SG&A for Bellicum Pharmaceuticals?
Bellicum Pharmaceuticals all-time high TTM selling, general & administrative expenses is $30.91 M
What is Bellicum Pharmaceuticals TTM SG&A year-on-year change?
Over the past year, BLCM TTM selling, general & administrative expenses has changed by -$2.35 B (-40692.32%)